Cargando…
Rivaroxaban Monotherapy in Patients With Atrial Fibrillation and Coronary Stenting at Multiple Vessels or the Left Main Trunk: The AFIRE Trial Subanalysis
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673635/ https://www.ncbi.nlm.nih.gov/pubmed/36285792 http://dx.doi.org/10.1161/JAHA.122.027107 |
| _version_ | 1784832985356304384 |
|---|---|
| author | Ishii, Mitsuru Akao, Masaharu Yasuda, Satoshi Kaikita, Koichi Ako, Junya Matoba, Tetsuya Nakamura, Masato Miyauchi, Katsumi Hagiwara, Nobuhisa Kimura, Kazuo Hirayama, Atsushi Matsui, Kunihiko Ogawa, Hisao |
| author_facet | Ishii, Mitsuru Akao, Masaharu Yasuda, Satoshi Kaikita, Koichi Ako, Junya Matoba, Tetsuya Nakamura, Masato Miyauchi, Katsumi Hagiwara, Nobuhisa Kimura, Kazuo Hirayama, Atsushi Matsui, Kunihiko Ogawa, Hisao |
| author_sort | Ishii, Mitsuru |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9673635 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96736352022-11-21 Rivaroxaban Monotherapy in Patients With Atrial Fibrillation and Coronary Stenting at Multiple Vessels or the Left Main Trunk: The AFIRE Trial Subanalysis Ishii, Mitsuru Akao, Masaharu Yasuda, Satoshi Kaikita, Koichi Ako, Junya Matoba, Tetsuya Nakamura, Masato Miyauchi, Katsumi Hagiwara, Nobuhisa Kimura, Kazuo Hirayama, Atsushi Matsui, Kunihiko Ogawa, Hisao J Am Heart Assoc Research Letter John Wiley and Sons Inc. 2022-10-26 /pmc/articles/PMC9673635/ /pubmed/36285792 http://dx.doi.org/10.1161/JAHA.122.027107 Text en © 2022 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
| spellingShingle | Research Letter Ishii, Mitsuru Akao, Masaharu Yasuda, Satoshi Kaikita, Koichi Ako, Junya Matoba, Tetsuya Nakamura, Masato Miyauchi, Katsumi Hagiwara, Nobuhisa Kimura, Kazuo Hirayama, Atsushi Matsui, Kunihiko Ogawa, Hisao Rivaroxaban Monotherapy in Patients With Atrial Fibrillation and Coronary Stenting at Multiple Vessels or the Left Main Trunk: The AFIRE Trial Subanalysis |
| title | Rivaroxaban Monotherapy in Patients With Atrial Fibrillation and Coronary Stenting at Multiple Vessels or the Left Main Trunk: The AFIRE Trial Subanalysis |
| title_full | Rivaroxaban Monotherapy in Patients With Atrial Fibrillation and Coronary Stenting at Multiple Vessels or the Left Main Trunk: The AFIRE Trial Subanalysis |
| title_fullStr | Rivaroxaban Monotherapy in Patients With Atrial Fibrillation and Coronary Stenting at Multiple Vessels or the Left Main Trunk: The AFIRE Trial Subanalysis |
| title_full_unstemmed | Rivaroxaban Monotherapy in Patients With Atrial Fibrillation and Coronary Stenting at Multiple Vessels or the Left Main Trunk: The AFIRE Trial Subanalysis |
| title_short | Rivaroxaban Monotherapy in Patients With Atrial Fibrillation and Coronary Stenting at Multiple Vessels or the Left Main Trunk: The AFIRE Trial Subanalysis |
| title_sort | rivaroxaban monotherapy in patients with atrial fibrillation and coronary stenting at multiple vessels or the left main trunk: the afire trial subanalysis |
| topic | Research Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673635/ https://www.ncbi.nlm.nih.gov/pubmed/36285792 http://dx.doi.org/10.1161/JAHA.122.027107 |
| work_keys_str_mv | AT ishiimitsuru rivaroxabanmonotherapyinpatientswithatrialfibrillationandcoronarystentingatmultiplevesselsortheleftmaintrunktheafiretrialsubanalysis AT akaomasaharu rivaroxabanmonotherapyinpatientswithatrialfibrillationandcoronarystentingatmultiplevesselsortheleftmaintrunktheafiretrialsubanalysis AT yasudasatoshi rivaroxabanmonotherapyinpatientswithatrialfibrillationandcoronarystentingatmultiplevesselsortheleftmaintrunktheafiretrialsubanalysis AT kaikitakoichi rivaroxabanmonotherapyinpatientswithatrialfibrillationandcoronarystentingatmultiplevesselsortheleftmaintrunktheafiretrialsubanalysis AT akojunya rivaroxabanmonotherapyinpatientswithatrialfibrillationandcoronarystentingatmultiplevesselsortheleftmaintrunktheafiretrialsubanalysis AT matobatetsuya rivaroxabanmonotherapyinpatientswithatrialfibrillationandcoronarystentingatmultiplevesselsortheleftmaintrunktheafiretrialsubanalysis AT nakamuramasato rivaroxabanmonotherapyinpatientswithatrialfibrillationandcoronarystentingatmultiplevesselsortheleftmaintrunktheafiretrialsubanalysis AT miyauchikatsumi rivaroxabanmonotherapyinpatientswithatrialfibrillationandcoronarystentingatmultiplevesselsortheleftmaintrunktheafiretrialsubanalysis AT hagiwaranobuhisa rivaroxabanmonotherapyinpatientswithatrialfibrillationandcoronarystentingatmultiplevesselsortheleftmaintrunktheafiretrialsubanalysis AT kimurakazuo rivaroxabanmonotherapyinpatientswithatrialfibrillationandcoronarystentingatmultiplevesselsortheleftmaintrunktheafiretrialsubanalysis AT hirayamaatsushi rivaroxabanmonotherapyinpatientswithatrialfibrillationandcoronarystentingatmultiplevesselsortheleftmaintrunktheafiretrialsubanalysis AT matsuikunihiko rivaroxabanmonotherapyinpatientswithatrialfibrillationandcoronarystentingatmultiplevesselsortheleftmaintrunktheafiretrialsubanalysis AT ogawahisao rivaroxabanmonotherapyinpatientswithatrialfibrillationandcoronarystentingatmultiplevesselsortheleftmaintrunktheafiretrialsubanalysis AT rivaroxabanmonotherapyinpatientswithatrialfibrillationandcoronarystentingatmultiplevesselsortheleftmaintrunktheafiretrialsubanalysis |